Nucleic Acid Testing Kits Market 2022-2028

Description

List of Tables

Title:Global Nucleic Acid Testing Kits Market Size, Share, and Trends Analysis Report, by Disease detection (Coronavirus, Cancer, Hepatitis, and Others), By End-User (Hospital and Clinic, and Academics and Research Institutes), Forecast Periods (2022-2028).

The global nucleic acid testing kits market is anticipated to grow at a substantial CAGR of 7.9% during the forecast period. The global nucleic acid testing kits market growth is being driven by the surging prevalence of COVID-19 in various parts of the globe, and rising investment by government and private agencies for novel biotechnological diagnostic techniques development along with high demand for technologically advanced diagnostic measures. Apart from these, the high adoption of nucleic acid tests for the treatment of genetically related diseases, cancerous diseases, and infectious diseases caused by bacteria or viruses is anticipated to spur their demand during the forecast period.

The global nucleic acid testing kits market is segmented based on disease detection and end-user. Based on disease detection, the market is sub-segmented into coronavirus, cancer, hepatitis, and others. Similarly, based on end-user, the market is sub-segmented into hospitals and clinics, and academics and research institutes.

Geographically, the nucleic acid testing kits market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Europe is expected to show notable growth in the market during the forecast period. The UK is the major economy contributing a significant share to the market. The exponential growth in positive COVID-19 cases gave rise to the demand for quick diagnostic test kits to detect the COVID-19 infection. As per the Worldometer, as of 8th May 2021, the total number of COVID-19 cases reported in the UK was 4.4 million. As of 6th May 2021, there have been 158 million tests (either processed or sent out) conducted across all 4 pillars in the UK. The hike in the number of COVID-19 diagnostic tests in the country boosted the market growth.

The major market players in the global nucleic acid testing kits market include Agilent Technology Inc., Abbott Laboratories, BGI Group, F.Hoffmann-La Roche, PerkinElmer, Inc., and Thermo Fisher Scientific, among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in July 2021, PerkinElmer, Inc., announced that the USFDA has approved its new coronavirus nucleic acid detection kit for an additional indication that permits the use of saliva as a specimen type. Moreover, in June 2021, Natera, Inc., and BGI Genomics Co., Ltd., (BGI Group) launched the BGI/Natera Signatera Assay. The product has been utilized in numerous clinical studies across non-small cell lung, bladder, breast, and colorectal cancers, to identify molecular residual disease (MRD). Similarly, in May 2020, Beckman Coulter Life Sciences launched RNAdvance Viral XP, a new RNA extraction kit validated for use in infectious disease and real-time PCR virus research.

Research Methodology

The market study of the global nucleic acid testing kits is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

Financial reports of companies involved in the market.

Whitepapers, research papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Nucleic acid testing kits Research and Analysis by Disease Detection
Global Nucleic acid testing kits Research and Analysis by End-User

The Report Covers:

Comprehensive research methodology of the global nucleic acid testing kits market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global nucleic acid testing kits market.
Insights about market determinants that are stimulating the global nucleic acid testing kits market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2026827

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global Nucleic Acid Testing Kits Industry
Recovery Scenario of Global Nucleic Acid Testing Kits Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. Key Strategy Analysis

4. Market Segmentation

4.1. Global Nucleic Acid Testing Kits Market by Disease detection
- 4.1.1. Coronavirus
- 4.1.2. Cancer
- 4.1.3. Hepatitis
- 4.1.4. Other
4.2. Global Nucleic Acid Testing Kits Market by End-User
- 4.2.1. Hospital and Clinics
- 4.2.2. Academics and Research Institutes

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
- 5.4.1. Latin America
- 5.4.2. Middle East & Africa

6. Company Profiles

6.1. Abbott Laboratories
6.2. Agilent Technology, Inc.
6.3. BGI Group
6.4. Biomedomics Inc.
6.5. BioMerieux S.A.
6.6. Bio-Rad Laboratories, Inc.
6.7. Danaher Corp.
6.8. F.Hoffmann-La Roche AG
6.9. Henry Schein Inc.
6.10. Illumina, Inc.
6.11. Innovita Biological Technology Co. Ltd.
6.12. Mayo Clinic Laboratories
6.13. Merck KGaA
6.14. Mylab Discovery Solutions Pvt. Ltd.
6.15. Qiagen N.V.
6.16. Robert Bosch GmbH
6.17. Siemens AG
6.18. Thermo Fisher Scientific, Inc.
6.19. Danaher Corp.
6.20. Epitope Diagnostics, Inc.